Guys...
I know things are not looking rosy on the
Guys...
I know things are not looking rosy on the surface.. yes, lots of cricket from MGMT as usual..
I've been thinking and trying to make some sense of some occurred events .
Facts... Discovery is getting a boat of cheaps shares.. easily ~20MM just the last several months from monthly interest payment..
If they chose to dump these shares on the open market, just 2 to 3MM could easily tanked the PPS under a penny... selling
1MM shares = 20K
10MM shares= 200K
20MM shares= 400K (assuming all shares can be sold at 2 cents)
You might be thinking.. it's free shares for them..no big deal.. any money from selling those shares will be pure profits. that's all true..
Also, dumping those shares could kill the mother goose.. How are they going to get their 5MM back? Collateral? what Collateral? Discovery is not stupid to take a chance to get their money through BK court. pushing OWCP behind the 8 ball not going to benefit them..
So, they want OWCP to do well as much we do. I think Discovery is on the same boat as us..of course, they are in front of the boat and we are on the bottom deck.
I could see Discovery keeping a healthy % of those cheap shares.. I just don't see them dumping their shares for a few hundred thousand and risk killing the OWCP in the process.
Bruce already posted that the current loan with Discovery, they can owned up to 4.99% and with option to increase the %. I just don't know all the specific of the loan.
ownership
4.99% = about 8MM
10% = about 17MM
For those of you sold, good for you. Your have more discipline then me.
If you are still on board, expect more drama ahead.
just thinking out loud.. if you other assessment, please share them with the group.
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Top 5 Most Recently Viewed Articles
Gentherm's Financial Performance for Second Quarter 2025 Gentherm, a global innovator in thermal management technologies, reported outstanding financial outcomes for the second quarter of 2025. The company's revenue reached $375 million, underscoring its strength in the automotive sector, particularly within Climate and Comfort Solutions. Record Achievements and New...
Continue Reading
DEALMining Achieves Major User Milestone In a significant accomplishment, DEALMining has proudly announced that its user base has exceeded 6.8 million globally, marking its status as one of the fastest-growing compliant cloud mining platforms in the world. This impressive growth showcases DEALMining's successful outreach across more than 200 countries and regions, as the...
Continue Reading
Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...
Continue Reading
Vivoryon Therapeutics N.V. Set to Report Financial Outcomes Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the entirety of 2024, along with insights into its operational achievements. The highly anticipated announcement is scheduled for April 29, 2025, aiming to shed light on the company’s progress in...
Continue Reading
Understanding the Economic Climate In finance, a stable economy is often described as a "Goldilocks" economy, where conditions are ideal for investments to flourish. Lately, we have witnessed an economy that consistently surpasses expectations, putting worries about downturns to rest. The Search for Economic Balance Investors are keen to find that sweet spot where...
Continue Reading